Skip to main content

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC

Position in WGS — GeneDx Holdings Corp.

CIK 1638555 Boston, MA

Position in WGS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$30,788,223
-$88,943,322 QoQ
Shares Held
479,418
-47.9% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 88.7678393385313.ToString("F0")% Shared 0.ToString("F0")% None 11.232160661468697.ToString("F0")%

Common Shares in WGS Over Time

Shares Held

Position Value (USD)

Derivatives in WGS

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$10,131,674
PutShares
77,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC holds $207,906,380 across 4 Diagnostics & Research names. WGS ranks #3 (14.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 WGS
GeneDx Holdings Corp.
This page
479,418 $30,788,223

All Filings in WGS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $30,788,223 479,418
2025-12-31 $119,731,545 920,587
2025-12-31 $10,131,674 77,900
2025-09-30 $26,396,300 245,000
2025-09-30 $88,731,108 823,567
2025-06-30 $70,826,232 767,265
2025-06-30 $80,057,232 867,265
2025-06-30 $9,231,000 100,000
2025-03-31 $106,501,980 1,202,529
2025-03-31 $8,838,787 99,800
2025-02-05 $95,863,710 1,426,968
2024-12-31 $58,072,649 755,564
2024-09-30 $7,339,785 172,945